76 related articles for article (PubMed ID: 12395334)
1. Differential expression of intestinal trefoil factor in biliary epithelial cells of primary biliary cirrhosis.
Kimura Y; Leung PS; Kenny TP; Van De Water J; Nishioka M; Giraud AS; Neuberger J; Benson G; Kaul R; Ansari AA; Coppel RL; Gershwin ME
Hepatology; 2002 Nov; 36(5):1227-35. PubMed ID: 12395334
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia.
Furuta GT; Turner JR; Taylor CT; Hershberg RM; Comerford K; Narravula S; Podolsky DK; Colgan SP
J Exp Med; 2001 May; 193(9):1027-34. PubMed ID: 11342587
[TBL] [Abstract][Full Text] [Related]
3. The role of biliary epithelial cells in the immunopathogenesis of non-suppurative destructive cholangitis in murine hepatic graft-versus-host disease.
Vierling JM; Hreha G; Wang H; Braun M
Trans Am Clin Climatol Assoc; 2011; 122():326-35. PubMed ID: 21686235
[TBL] [Abstract][Full Text] [Related]
4. T-lymphocyte subsets in liver tissues of patients with primary biliary cirrhosis (PBC), patients with primary sclerosing cholangitis (PSC), and normal controls.
Si L; Whiteside TL; Schade RR; Starzl TE; Van Thiel DH
J Clin Immunol; 1984 Jul; 4(4):262-72. PubMed ID: 6611346
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor alpha-mediated mitochondrial damage in intrahepatic bile duct epithelial cells leading to the pathogenesis of primary biliary cholangitis.
Liang M; Ye S; Jing R; Zhu B; Yuan W; Chu X; Li Y; Zhang W
Environ Toxicol; 2023 Dec; 38(12):2803-2818. PubMed ID: 37740728
[TBL] [Abstract][Full Text] [Related]
6. Obliteration of portal venules contributes to portal hypertension in biliary cirrhosis.
Shan S; Zhao X; Wood-Trageser MA; Hu D; Liu L; Qi B; Jian J; Wang P; Lv W; Hu C
J Pathol; 2024 Jun; 263(2):178-189. PubMed ID: 38551075
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of TNFRSF14 and LIGHT in biliary epithelial cells of patients with primary sclerosing cholangitis.
Kanai S; Fujiwara H; Mizuno S; Kishikawa T; Nakatsuka T; Hamada T; Tanaka M; Arita J; Nakai Y; Isayama H; Kasuga M; Tateishi R; Tateishi K; Ushiku T; Hasegawa K; Koike K; Fujishiro M
Dig Liver Dis; 2024 Feb; 56(2):305-311. PubMed ID: 37722959
[TBL] [Abstract][Full Text] [Related]
8. Primary biliary cholangitis: molecular pathogenesis perspectives and therapeutic potential of natural products.
Zhao Y; Wei S; Chen L; Zhou X; Ma X
Front Immunol; 2023; 14():1164202. PubMed ID: 37457696
[TBL] [Abstract][Full Text] [Related]
9. Biliary epithelium: A neuroendocrine compartment in cholestatic liver disease.
Ehrlich L; Scrushy M; Meng F; Lairmore TC; Alpini G; Glaser S
Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):296-305. PubMed ID: 29678444
[TBL] [Abstract][Full Text] [Related]
10. Zebrafish ppp1r21 mutant as a model for the study of primary biliary cholangitis.
Wu C; Zhang W; Luo Y; Cheng C; Wang X; Jiang Y; Li S; Luo L; Yang Y
J Genet Genomics; 2023 Dec; 50(12):1004-1013. PubMed ID: 37271428
[TBL] [Abstract][Full Text] [Related]
11. Primary Biliary Cholangitis: Pathophysiology.
Houri I; Hirschfield GM
Clin Liver Dis; 2024 Feb; 28(1):79-92. PubMed ID: 37945164
[TBL] [Abstract][Full Text] [Related]
12. Current Perspectives on the Molecular and Clinical Relationships between Primary Biliary Cholangitis and Hepatocellular Carcinoma.
Floreani A; Gabbia D; De Martin S
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396870
[TBL] [Abstract][Full Text] [Related]
13. Expression of E-cadherin by CD8
Davies SP; Ronca V; Wootton GE; Krajewska NM; Bozward AG; Fiancette R; Patten DA; Yankouskaya K; Reynolds GM; Pat S; Osei-Bordom DC; Richardson N; Grover LM; Weston CJ; Oo YH
Nat Commun; 2024 Jan; 15(1):853. PubMed ID: 38286990
[TBL] [Abstract][Full Text] [Related]
14. Canal of Hering loss is an initiating step for primary biliary cholangitis (PBC): A hypothesis.
Theise ND; Crawford JM; Nakanuma Y; Quaglia A
Med Hypotheses; 2020 Mar; 140():109680. PubMed ID: 32240960
[TBL] [Abstract][Full Text] [Related]
15. Autocrine regulation of biliary pathology by activated cholangiocytes.
Jensen K; Marzioni M; Munshi K; Afroze S; Alpini G; Glaser S
Am J Physiol Gastrointest Liver Physiol; 2012 Mar; 302(5):G473-83. PubMed ID: 22194419
[TBL] [Abstract][Full Text] [Related]
16. Functional anatomy of normal bile ducts.
Strazzabosco M; Fabris L
Anat Rec (Hoboken); 2008 Jun; 291(6):653-60. PubMed ID: 18484611
[TBL] [Abstract][Full Text] [Related]
17. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor.
Mashimo H; Wu DC; Podolsky DK; Fishman MC
Science; 1996 Oct; 274(5285):262-5. PubMed ID: 8824194
[TBL] [Abstract][Full Text] [Related]
18. Site-characteristic expression and induction of trefoil factor family 1, 2 and 3 and malignant brain tumor-1 in normal and diseased intrahepatic bile ducts relates to biliary pathophysiology.
Sasaki M; Tsuneyama K; Saito T; Kataoka H; Mollenhauer J; Poustka A; Nakanuma Y
Liver Int; 2004 Feb; 24(1):29-37. PubMed ID: 15101998
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus-associated pruritus: Etiopathogenesis and therapeutic strategies.
Alhmada Y; Selimovic D; Murad F; Hassan SL; Haikel Y; Megahed M; Hannig M; Hassan M
World J Gastroenterol; 2017 Feb; 23(5):743-750. PubMed ID: 28223719
[TBL] [Abstract][Full Text] [Related]
20. Deletion of Galectin-3 Enhances Xenobiotic Induced Murine Primary Biliary Cholangitis by Facilitating Apoptosis of BECs and Release of Autoantigens.
Arsenijevic A; Milovanovic M; Milovanovic J; Stojanovic B; Zdravkovic N; Leung PS; Liu FT; Gershwin ME; Lukic ML
Sci Rep; 2016 Mar; 6():23348. PubMed ID: 26996208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
